-spermia, Further information: Testicular infertility factors |
Aspermia—lack of semen; anejaculation |
Asthenozoospermia—sperm motility below lower reference limit |
Azoospermia—absence of sperm in the ejaculate |
Hyperspermia—semen volume above upper reference limit |
Hypospermia—semen volume below lower reference limit |
Oligospermia—total sperm count below lower reference limit |
Necrospermia—absence of living sperm in the ejaculate |
Teratospermia—fraction of normally formed sperm below lower reference limit |
In medicine, hyperspermia is a condition in which a male has an abnormally large amount of semen or ejaculate volume [1] and is generally defined when the ejaculate is above 6 mL. [2] It is the opposite of hypospermia, which is defined as a semen volume of less than 1.5 mL.
Hyperspermia alone does not appear to influence sperm health. However, large volumes of ejaculate may have lower relative volumes of sperm, leading to low fertility. [3] [1]
In some cases, high semen volumes can be a symptom of male accessory gland infection. [4]
Coitus interruptus, also known as withdrawal, pulling out or the pull-out method, is an act of birth control during penetrative sexual intercourse, whereby the penis is withdrawn from a vagina prior to ejaculation so that the ejaculate (semen) may be directed away in an effort to avoid insemination.
The prostate is an accessory gland of the male reproductive system and a muscle-driven mechanical switch between urination and ejaculation. It is found in all male mammals. It differs between species anatomically, chemically, and physiologically. Anatomically, the prostate is found below the bladder, with the urethra passing through it. It is described in gross anatomy as consisting of lobes and in microanatomy by zone. It is surrounded by an elastic, fibromuscular capsule and contains glandular tissue, as well as connective tissue.
Pre-ejaculate is a clear, colorless, viscous fluid that is emitted from the urethra of the penis during sexual arousal and in general during sexual activity. It is similar in composition to semen but has distinct chemical differences. The presence of sperm in the fluid is variable from low to absent. Pre-ejaculate functions as a lubricant and an acid neutralizer.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
Retrograde ejaculation occurs when semen which would be ejaculated via the urethra is redirected to the urinary bladder. Normally, the sphincter of the bladder contracts before ejaculation, inhibiting urination and preventing a reflux of semen into the bladder. The semen is forced to exit via the urethra, the path of least resistance. When the bladder sphincter does not function properly, retrograde ejaculation may occur. It can also be induced deliberately by a male as a primitive form of male birth control or as part of certain alternative medicine practices. The retrograde-ejaculated semen is excreted from the bladder during the next urination.
The seminal vesicles are a pair of convoluted tubular accessory glands that lie behind the urinary bladder of male mammals. They secrete fluid that largely composes the semen.
The ejaculatory ducts are paired structures in the male reproductive system. Each ejaculatory duct is formed by the union of the vas deferens with the duct of the seminal vesicle. They pass through the prostate, and open into the urethra above the seminal colliculus. During ejaculation, semen passes through the prostate gland, enters the urethra and exits the body via the urinary meatus.
The male reproductive system consists of a number of sex organs that play a role in the process of human reproduction. These organs are located on the outside of the body, and within the pelvis.
Aspermia is the complete lack of semen with ejaculation. It is associated with infertility.
Hypospermia is a condition in which a man has an unusually low ejaculate volume, less than 1.5 mL. It is the opposite of hyperspermia, which is a semen volume of more than 5.5 mL. It should not be confused with oligospermia, which means low sperm count. Normal ejaculate when a man is not drained from prior sex and is suitably aroused is around 1.5–6 mL, although this varies greatly with mood, physical condition, and sexual activity. Of this, around 1% by volume is sperm cells. The U.S.-based National Institutes of Health defines hypospermia as a semen volume lower than 2 mL on at least two semen analyses.
Male infertility refers to a sexually mature male's inability to impregnate a fertile female. In humans, it accounts for 40–50% of infertility. It affects approximately 7% of all men. Male infertility is commonly due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity. More recently, advance sperm analyses that examine intracellular sperm components are being developed.
Spermatogenesis arrest is known as the interruption of germinal cells of specific cellular type, which elicits an altered spermatozoa formation. Spermatogenic arrest is usually due to genetic factors resulting in irreversible azoospermia. However some cases may be consecutive to hormonal, thermic, or toxic factors and may be reversible either spontaneously or after a specific treatment. Spermatogenic arrest results in either oligospermia or azoospermia in men. It is quite a difficult condition to proactively diagnose as it tends to affect those who have normal testicular volumes; a diagnosis can be made however through a testicular biopsy.
A semen analysis, also called seminogram or spermiogram, evaluates certain characteristics of a male's semen and the sperm contained therein. It is done to help evaluate male fertility, whether for those seeking pregnancy or verifying the success of vasectomy. Depending on the measurement method, just a few characteristics may be evaluated or many characteristics may be evaluated. Collection techniques and precise measurement method may influence results. The assay is also referred to as ejaculate analysis, human sperm assay (HSA), sperm function test, and sperm assay.
Semen quality is a measure of male fertility, a measure of the ability of sperm in semen to accomplish fertilization. Semen quality involves both sperm quantity and quality. Semen quality is a major factor for fertility.
In human anatomy, the penis is an external sex organ through which males urinate and ejaculate. Together with the testes and surrounding structures, the penis functions as part of the male reproductive system.
Semen, also known as seminal fluid, is a bodily fluid that contains spermatozoa. Spermatozoa are secreted by the male gonads and other sexual organs of male or hermaphroditic animals and can fertilize the female ovum. In placental mammals, semen also contains secretions from the male accessory glands and is discharged from the penis through the urethral orifice during ejaculation. In humans, seminal fluid contains several components besides spermatozoa: proteolytic and other enzymes as well as fructose are elements of seminal fluid which promote the survival of spermatozoa and provide a medium through which they can move or "swim". The fluid is adapted to be discharged deep into the vagina, so the spermatozoa can pass into the uterus and form a zygote with an egg.
Ejaculation is the discharge of semen from the penis through the urethra. It is the final stage and natural objective of male sexual stimulation, and an essential component of natural conception. After forming an erection, many men emit pre-ejaculatory fluid during stimulation prior to ejaculating. Ejaculation involves involuntary contractions of the pelvic floor and is normally linked with orgasm. It is a normal part of male human sexual development.
Male accessory gland infection (MAGI) is a condition with signs of inflammation involving one or more sites in the male genital tract. Diagnosis is made according to parameters defined by the World Health Organization, and it is particularly made in relation to infectious or inflammatory causes of male infertility.
Sperm competition is a form of post-copulatory sexual selection whereby male sperm simultaneously physically compete to fertilize a single ovum. Sperm competition occurs between sperm from two or more rival males when they make an attempt to fertilize a female within a sufficiently short period of time. This results primarily as a consequence of polyandrous mating systems, or due to extra-pair copulations of females, which increases the chance of cuckoldry, in which the male mate raises a child that is not genetically related to him. Sperm competition among males has resulted in numerous physiological and psychological adaptations, including the relative size of testes, the size of the sperm midpiece, prudent sperm allocation, and behaviors relating to sexual coercion, however this is not without consequences: the production of large amounts of sperm is costly and therefore, researchers have predicted that males will produce larger amounts of semen when there is a perceived or known increase in sperm competition risk.
Seminal fluid proteins (SFPs) or accessory gland proteins (Acps) are one of the non-sperm components of semen. In many animals with internal fertilization, males transfer a complex cocktail of proteins in their semen to females during copulation. These seminal fluid proteins often have diverse, potent effects on female post-mating phenotypes. SFPs are produced by the male accessory glands.
{{cite journal}}
: CS1 maint: DOI inactive as of December 2024 (link)